Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization

Cancer Genetics and Cytogenetics

Volumn 155, Issue 2, 2004, Pages 108-118

  Somiari, Stella B ^a   Shriver, Craig D ^b   He, Jing ^a   Parikh, Kishan ^c   Jordan, Rick ^a   Hooke, Jeffrey ^b   Hu, Hai ^a   Deyarmin, Brenda ^a   Lubert, Susan ^a   Malicki, Lisa ^a   Heckman, Caroline ^a   Somiari, Richard I ^d  

^a WINDBER RESEARCH INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Johnstown PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GENOMIC DNA;

ARTICLE; BREAST CARCINOMA; BREAST INFILTRATING DUCTAL CARCINOMA; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CHROMOSOME 1; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCATION; GENETIC DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR GENETICS; ONCOGENE NEU; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DNA PROBES; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENES, ERBB-2; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PILOT PROJECTS; TUMOR BURDEN;

EID: 6344228180     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.02.023     Document Type: Article

References (36)

1. American Cancer Society. How many women get breast cancer? Cancer Reference Information 2003. Available at: http://www.cancer.org/docroot/CRI/ content/CRI_2_2_1X_How_many_people_get_breast_cancer_5.asp?sitearea= Accessed August 29, 2003.
2. M.F. Press, L. Bernstein, P.A. Thomas, L.F. Meisner, J.Y. Zhou, Y. Ma, G. Hung, R.A. Robinson, C. Harris, A. El-Naggar, D.J. Slamon, R.N. Phillips, J.S. Ross, S.R. Wolman, and K.J. Flom HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas J Clin Oncol 5 1997 2894 2904
3. M. Dowsett, T. Cooke, I. Ellis, W.J. Gullick, B. Gusterson, E. Mallon, and R. Walker Assessment of HER2 status in breast cancer: why, when and how? Eur J Cancer 36 2000 170 176
4. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2001 127 137
5. F. Meric, M.C. Hung, G.N. Hortobagyi, and K.K. Hunt HER2/neu in the management of invasive breast cancer J Am Coll Surg 194 2002 488 501
6. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ulrich, and W.L. McGuire Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene Science 235 1987 177 182
7. M. Konigshoff, J. Wilhelm, R.M. Bohle, A. Pingoud, and M. Hahn HER-2/neu gene copy number quantified by real time PCR: Comparison of gene amplification, heterozygosity and immunohistochemical status in breast tissue Clin Chem 49 2003 219 229
8. J. Baselga, L. Norton, J. Albanell, Y.M. Kim, and J. Mendelsohn Recombinant humanized anti-HER2 antibody (Herceptin) enhances the anti tumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts Cancer Res 58 1998 2825 2831
9. G. Pauletti, S. Dandekar, H. Rong, L. Ramos, H. Peng, R. Seshadri, and D.J. Slamon Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry J Clin Oncol 18 2000 3651 3664
10. R. Simon, A. Nocito, T. Hubscher, C. Bucher, J. Torhorst, P. Schraml, L. Bubendorf, M.M. Mihatsch, H. Moch, K. Wilber, A. Schotzau, J. Kononen, and G. Sauter Patterns of HER-2/neu amplification and over-expression in primary and metastatic breast cancer J Natl Cancer Inst 93 2001 1141 1146
11. O.P. Kallionemi, A. Kallionemi, J. Piper, J. Isola, F.M. Waldman, W.J. Gray, and D. Pinkel Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors Genes Chromosomes Cancer 10 1994 231 243
12. G.O. Ness, H. Lybaek, and G. Houge Usefulness of high-resolution comparative genomic hybridization (CGH) for detecting and characterizing constitutional chromosome abnormalities Am J Med Genet 113 2002 125 136
13. T. Taguchi, G.Z. Cheng, D.W. Bell, B. Balsara, Z. Liu, J.M. Siegfried, and J.R. Testa Combined chromosome microdissection and comparative genomic hybridization detect multiple sites of amplification of DNA in a human lung carcinoma cell line Genes Chromosomes Cancer 20 1997 208 212
14. M.A. Rigola, C. Casadevall, M. Bernues, M.R. Caballin, C. Fuster, A. Gelabert, J. Egozcue, and R. Miro Analysis of kidney tumors by comparative genomic hybridization and conventional cytogenetics Cancer Genet Cytogenet 137 2002 49 53
15. M. Chujo, T. Noguchi, T. Miura, M. Arinaga, Y. Uchida, and Y. Tagawa Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung Lung Cancer 38 2002 23 29
16. K. Kasahara, T. Taguchi, I. Yamasaki, M. Kamada, K. Yuri, and T. Shuin Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization Cancer Genet Cytogenet 137 2002 59 63
17. S. Solinas-Toldo, S. Lampel, S. Stilgenbauer, J. Nickolenko, A. Benner, H. Dohner, T. Cremer, and P. Lichter Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances Genes Chromosomes Cancer 20 1997 399 407
18. D. Pinkel, R. Segraves, D. Sudar, S. Clark, I. Poole, D. Kowbel, C. Collins, W.L. Kuo, C. Chen, Y. Zhai, S.H. Dairkee, B.M. Ljng, J.W. Gray, and D.G. Albertson High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays Nat Genet 20 1998 207 211
19. M.A. Heiskanen, M.L. Bittner, Y. Chen, J. Khan, K.E. Adler, J.M. Trent, and P.S. Meltzer Detection of gene amplification by genomic hybridization to cDNA microarrays Cancer Res 60 2000 799 802
20. A. Martinez-Ramirez, M. Urioste, M.J. Calasanz, J.C. Cigudosa, and J. Benitez Array comparative genomic hybridization analysis of myelodysplastic syndromes with complex karyotypes: A technical evaluation Cancer Genet Cytogenet 144 2003 87 89
21. D.L. Persons, M.M. Bui, M.C. Lowery, H.F. Mark, J.F. Yung, J.M. Birkmeier, E.Y. Wong, S.J. Yang, and S. Masood Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study Ann Clin Lab Sci 30 2000 41 48
22. M.B. Eisen, P.T. Spellman, P.O. Brown, and D. Botstein Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci USA 95 1998 14863 14868
23. J.R. Pollack, C.M. Perou, A.A. Alizadeh, M.B. Eisen, A. Pergamenschikov, C.F. Williams, S.S. Jeffrey, D. Botstein, and P.O. Brown Genome-wide analysis of DNA copy-number changes using cDNA microarrays Nat Genet 23 1999 41 46
24. J. Nishio, H. Iwasaki, M. Ishiguru, Y. Ohjimi, N. Nishimura, T. Koga, T. Kawarabayashi, Y. Kaneko, and M. Kikuchi Establishment of a new human fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridization Cancer Genet Cytogenet 144 2003 44 51
25. S.H. Koo, K.C. Kwon, C.H. Ihm, Y.M. Jeon, J.W. Park, and C.K. Sul Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis Cancer Genet Cytogenet 15 1999 87 93
26. Y. Wu, B. Han, H. Sheng, M. Lin, P.A. Moore, J. Zhang, and J. Wu Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients Int J Cancer 105 2003 724 732
27. E. Pagano, and J.C. Calvo ErbB2 and EGFR are down-modulated during differentiation of 3T3-L1 preadipocutes J Cell Biochem 90 2003 561 572
28. J.S. Kruger, and K.B. Reddy Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells Mol Cancer Res 1 2003 801 809
29. M. Karbownik, E. Brzezianska, K. Zasada, and A. Lewinski Expression of genes for certain enzymes of pyrimidine and purine salvage pathway in peripheral blood leukocytes collected from patients with Graves' or Hashimoto's disease J Cell Biochem 8 2003 550 555
30. F. Zhang, H. Li, A.R. Pendleton, J.G. Robinson, K.O. Monson, B.K. Murray, and K.L. O'Neill Thymidine Kinase 1 immunoassay: a potential marker for breast cancer Cancer Detect Prev 25 2001 8 15
31. Q. He, L. Zou, P.A. Zhang, J.X. Lui, S. Skog, and T. Fornander The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody Int J Biol Markers 15 2000 139 146
32. S.L. Gilles, S. Romain, P. Casellas, L. Ouafik, F. Fina, T. Combes, V. Vuaroquaux, J.F. Seitz, P. Bonnier, S. Galiegue, P. Carayon, and P.M. Martin Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer Int J Biol Marker 8 2003 1 6
33. F.C. Schmitt, and J.S. Reis-Filho C-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate and how significant Breast Cancer Res 5 2003 188 191
34. J. Palacios, E. Honrado, A. Osorio, A. Cazorla, D. Sarrio, A. Barroso, S. Rodriguez, J.C. Cigudosa, O. Diez, C. Alonso, E. Lerma, L. Sanchez, C. Riva, and J. Benitez Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers Clin Cancer Res 9 2003 3606 3614
35. Q.-J. He, W.-F. Zeng, J.S.T. Sham, D. Xie, X.-W. Yang, H.-L. Lin, W.-H. Zhan, F. Lin, S.-D. Zeng, D. Nie, L.-F. Ma, C.-J. Li, S. Lu, and X.-Y. Guan Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients Cancer Genet Cytogenet 144 2003 112 118
36. C. Aciero, S. Somiari, C. Shriver, H. Brzeski, R. Jordan, H. Hu, D. Ellsworth, and R.I. Somiari Functional relationship and gene ontology classification of breast cancer biomarkers Int. J Biol Markers 18 2003 241 272